Skip to main content

Overview of CT and MRI Techniques of the Liver

  • Chapter
  • First Online:
Cross-Sectional Imaging of the Abdomen and Pelvis

Abstract

This chapter provides an illustrative practical overview of the utility of most CT and MRI techniques used for the clinical evaluation of the liver.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dwyer A, et al. Influence of glycogen on liver density: computed tomography from a metabolic perspective. J Comput Assist Tomogr. 1983;7(1):70–3.

    Article  CAS  Google Scholar 

  2. Kamel IR, Liapi E, Fishman EK. Multidetector CT of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19(1):63–89.

    Article  Google Scholar 

  3. Monzawa S, et al. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol. 2007;188(1):147–53.

    Article  Google Scholar 

  4. Yeh BM, et al. Dual-energy and low-kVp CT in the abdomen. AJR Am J Roentgenol. 2009;193(1):47–54.

    Article  Google Scholar 

  5. Mulkens TH. Dose management in Multidetector Computed Tomography (MDCT): modalities for dose reduction and clinical studies. Belgium: Universiteit Antwerpen; 2008. 223.

    Google Scholar 

  6. Boll DT, Merkle EM. Diffuse liver disease: strategies for hepatic CT and MR imaging. Radiographics. 2009;29(6):1591–614.

    Article  Google Scholar 

  7. Goshima S, et al. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. AJR Am J Roentgenol. 2006;187(1):W25–32.

    Article  Google Scholar 

  8. Yu JS, et al. Hepatic MRI using the double-echo chemical shift phase-selective gradient-echo technique. AJR Am J Roentgenol. 2007;188(1):W49–56.

    Article  Google Scholar 

  9. Deshmane A, et al. Parallel MR imaging. J Magn Reson Imaging. 2012;36(1):55–72.

    Article  Google Scholar 

  10. Alustiza JM, Castiella A. Liver fat and iron at in-phase and opposed-phase MR imaging. Radiology. 2008;246(2):641.

    Article  Google Scholar 

  11. Westbrook C, Roth CK, Talbot J. MRI in practice. 3rd ed. Malden: Blackwell; 2005. xii, 410 p.

    Google Scholar 

  12. Low RN. Abdominal MRI, advances in the detection of liver tumours and characterisation. Lancet Oncol. 2007;8(6):525–35.

    Article  Google Scholar 

  13. Li T, Mirowitz SA. Fast T2-weighted MR imaging: impact of variation in pulse sequence parameters on image quality and artifacts. Magn Reson Imaging. 2003;21(7):745–53.

    Article  Google Scholar 

  14. Huang J, et al. Utility of breath-hold fast-recovery fast spin-echo t2 versus respiratory-triggered fast spin-echo T2 in clinical hepatic imaging. AJR Am J Roentgenol. 2005;184(3):842–6.

    Article  Google Scholar 

  15. Semelka RC. Abdominal-pelvic MRI. Hoboken: Wiley; 2006.

    Google Scholar 

  16. Leyendecker JR, Brown JJ, Merkle EM. Practical guide to abdominal & pelvic MRI. 2nd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011. ix, 406 p.

    Google Scholar 

  17. Morrin MM, Rofsky NM. Techniques for liver MR imaging. Magn Reson Imaging Clin N Am. 2001;9(4):675–96. v.

    CAS  PubMed  Google Scholar 

  18. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254(1):47–66.

    Article  Google Scholar 

  19. Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging. 2007;25(4):848–58.

    Article  Google Scholar 

  20. Chandarana H, Taouli B. Diffusion-weighted MRI and liver metastases. Magn Reson Imaging Clin N Am. 2010;18(3):451–64. x.

    Article  Google Scholar 

  21. Bhosale P, Ma J, Choi H. Utility of the FIESTA pulse sequence in body oncologic imaging: review. AJR Am J Roentgenol. 2009;192(6 Suppl):S83–93. Quiz S94–7.

    Article  Google Scholar 

  22. Motosugi U, et al. Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol. 2009;19(11):2623–9.

    Article  Google Scholar 

  23. Tsao J, Kozerke S. MRI temporal acceleration techniques. J Magn Reson Imaging. 2012;36(3):543–60.

    Article  Google Scholar 

  24. Yoon SH, et al. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol. 2009;193(6):W482–9.

    Article  Google Scholar 

  25. Sadowski EA, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243(1):148–57.

    Article  Google Scholar 

  26. Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol. 2004;14(4):559–78.

    Article  Google Scholar 

  27. Karabulut N, Cakmak V, Kiter G. Confident diagnosis of bronchobiliary fistula using contrast-enhanced magnetic resonance cholangiography. Korean J Radiol. 2010;11(4):493–6.

    Article  Google Scholar 

  28. Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect? J Hepatol. 2012;57(2):421–9.

    Article  Google Scholar 

  29. Husarik DB, et al. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Acad Radiol. 2011;18(12):1549–54.

    Article  Google Scholar 

  30. Gschwend S, et al. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Invest Radiol. 2011;46(9):556–66.

    Article  CAS  Google Scholar 

  31. Tamada T, et al. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging. 2009;29(3):636–40.

    Article  Google Scholar 

  32. Tamada T, et al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol. 2011;80(3):e311–6.

    Article  Google Scholar 

  33. Petersein J, et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging–a multicenter phase III clinical study. Radiology. 2000;215(3):727–36.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tara Sagebiel MD .

Editor information

Editors and Affiliations

Appendix A

Appendix A

Table 1.1 MRI sequence vendor specific nomenclature

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sagebiel, T., Szkarluk, J. (2015). Overview of CT and MRI Techniques of the Liver. In: Elsayes, K.M. (eds) Cross-Sectional Imaging of the Abdomen and Pelvis. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1884-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1884-3_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1883-6

  • Online ISBN: 978-1-4939-1884-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics